UNSPSC 51112405: Procarbazine hydrochloride

This classification denotes an antineoplastic agent with the molecular formula C12H19N3O.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XH0NPH5ZX8, chemically known as p-toluamide, n-isopropyl-.alpha.- (2-methylhydrazino)-, monohydrochloride but more generally known as procarbazine hydrochloride, which bears US NIH Compound Identifier 4915. European Medicines Agency schedules Procarbazine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB15017MIG.

UNSPSC 51112405 Procarbazine hydrochloride is a Commodity code covering the pharmaceutical agent procarbazine hydrochloride, a chemotherapy drug used in cancer treatment regimens. State and local governments procure this medication primarily through public health departments, correctional health systems, state hospitals, and county health agencies to support oncology services and inmate medical care. The drug is typically sourced through established pharmaceutical supply chains and state Medicaid programs that negotiate pricing and volume commitments with manufacturers and wholesalers. Procurement occurs as part of routine pharmaceutical inventory management, often bundled with broader oncology medication acquisitions or specialty pharmacy contracts.

The source provided contains no recent state and local contract opportunities tagged to this code. Without posted solicitations, response dates, issuing bodies, or geographic activity markers in the record, no representative opportunities or regional concentration can be identified from current market signals.